Literature DB >> 28120592

Profile of People Who Inject Drugs in Tehran, Iran.

Masoumeh Amin-Esmaeili1, Afarin Rahimi-Movaghar1, Maryam Gholamrezaei2, Emran Mohammad Razaghi3.   

Abstract

The marked shift in the patterns of drug use in Iran, from opium smoking to injecting drug use, has led to serious health-related outcomes. This study was designed to explore characteristics of people who inject drugs (PWID) in Tehran, Iran. Nine hundred and four PWID were recruited from treatment and harm reduction facilities, as well as drug user hangouts in public areas in Tehran. Participants were interviewed using the Persian version of the World Health Organization Drug Injecting Study Phase II questionnaire. The median age at the time of the first illegal drug use, at the time of the first injection and current age was 20, 24 and 32, respectively. In more than 80% of the cases, the first drug used was opium. The transition from the first drug use to the first drug injection occurred after an average of 6.6 and 2.7 years for those who had started drug use with opium and heroin, respectively. Two-thirds of the participants shared injecting equipment within the last 6 months. Difficulty in obtaining sterile needles and thehigh cost of syringes were reported as the major reasons for needle/syringe sharing. Approximately 80% of community-recruited PWID reported difficulties in using treatment or harm reduction services. Self-detoxification and forced detoxification were the most common types of drug abuse treatment in alifetime. Despite a dramatic shift in drug policy in Iran during the past few years, wider coverage of harm reduction services, improvement of the quality of services, and education about such services are still necessary.

Entities:  

Keywords:  Health service utilization; Intravenous substance abuse; Iran; Risk behaviors

Mesh:

Substances:

Year:  2016        PMID: 28120592

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  7 in total

1.  Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran.

Authors:  Aryan Esmaeili; Mostafa Shokoohi; Ahmad Danesh; Hamid Sharifi; Mohammad Karamouzian; AliAkbar Haghdoost; Armita Shahesmaeili; Samaneh Akbarpour; Meghan D Morris; Ali Mirzazadeh
Journal:  AIDS Behav       Date:  2019-06

2.  Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks.

Authors:  Armita Shahesmaeili; Ali Mirzazadeh; Willi McFarland; Hamid Sharifi; Ali Akbar Haghdoost; Hamid Soori
Journal:  AIDS Behav       Date:  2018-07

3.  Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran.

Authors:  Masoomeh Koozegar; Armita Shahesmaeili; Mehdi Noroozi
Journal:  Addict Health       Date:  2018-01

4.  When and how do individuals transition from regular drug use to injection drug use in Uganda? Findings from a rapid assessment.

Authors:  Matayo Baluku; Twaibu Wamala
Journal:  Harm Reduct J       Date:  2019-12-23

Review 5.  Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.

Authors:  Abdolhalim Rajabi; Heidar Sharafi; Seyed Moayed Alavian
Journal:  Harm Reduct J       Date:  2021-01-22

6.  Prevalence and Correlates of Providing and Receiving Assistance With the Transition to Injection Drug Use.

Authors:  Rachel E Gicquelais; Dan Werb; Charles Marks; Carolyn Ziegler; Shruti H Mehta; Becky L Genberg; Ayden I Scheim
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 4.280

Review 7.  Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis.

Authors:  Yasna Rostam-Abadi; Hossein Rafiemanesh; Jaleh Gholami; Behrang Shadloo; Masoumeh Amin-Esmaeili; Afarin Rahimi-Movaghar
Journal:  Harm Reduct J       Date:  2020-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.